Literature DB >> 9503496

[An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].

A Aplogan, E Batchassi, Y Yakoua, A Croisier, A Aleki, M Schlumberger, S Molina, M Sidatt, A V Kaninda.   

Abstract

Neisseria meningitidis is responsible for high levels of morbidity and mortality in the developing countries of the African meningitis belt. There are frequent meningococcal meningitis epidemics in this region affecting almost 1,000 people in every 100,000 (1%). Epidemics generally occur during the dry season but the interval between epidemics is variable (between 2 and 25 years). The reasons for these recurrent epidemics are unclear. There is a safe and effective polysaccharide vaccine against meningococci A and C. Unfortunately, the immunity it provides decreases with time, especially in young children (aged less than 5 years) and it is thus not included in the Expanded Program on Immunization (EPI). WHO recommends mass vaccination using a threshold approach. This control strategy is effective if vaccination begins very soon after the threshold is crossed. There was an outbreak of group A meningococcal meningitis in the Savanes region of northern Togo in December 1996. The national surveillance system put out an alert and control measures were implemented. These involved improvement of the surveillance system, and containment immunization in villages for early cases followed by a mass immunization campaign in the entire region, distribution of oily chloramphenicol and decentralized case management. The target population for mass vaccination included everyone older than 6 months of age living in the Savanes region. The aim was to vaccinate at least 80% of the target population. There were 2,992 cases of meningitis reported in the Savanes region between December 1996 and May 1997 (in a population of about 500,000). This gives a cumulative incidence rate of 581 per 100,000 population. The epidemic was bimodal, with the first peak in the number of cases occurring at the end of January and the second peak in March. There were 60,700 vaccinations in two of the four districts of the region in December and January, as part of the containment strategy and 346,469 vaccinations in the four districts of the region during February, as part of the mass vaccination campaign. By the end of the mass campaign, 67.3% of the target population in the region as a whole had been vaccinated, with 61% vaccinated in the Kpendjal district and 78% in the Oti district. There was an increase in the number of cases 2 weeks after the end of the mass vaccination campaign. This was attributed to the inadequate level of vaccination achieved. Only 52% of the urban population of Dapaong were vaccinated. The national surveillance system put out an alert early in the epidemic. The intervention was planned and adapted according to the progression of the epidemic, and national and international efforts were well coordinated. This emphasizes the importance of a rapid reaction from the surveillance system and of the choice of strategy for dealing with meningitis epidemics in sub-Sahelian Africa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9503496

Source DB:  PubMed          Journal:  Sante        ISSN: 1157-5999


  4 in total

Review 1.  Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.

Authors:  Idris Mohammed; Garba Iliyasu; Abdulrazaq Garba Habib
Journal:  Pathog Glob Health       Date:  2017-01-12       Impact factor: 2.894

2.  Distribution pattern of poliovirus potentially infectious materials in the phase 1b medical laboratories containment in conformity with the global action plan III.

Authors:  Bassey Enya Bassey; Fiona Braka; Faisal Shuaib; Richard Banda; Sisay Gashu Tegegne; Johnson Muluh Ticha; Walla Hamisu Abdullalhi; Olatunji Mathew Kolawole; Yusuf Kabir
Journal:  BMC Public Health       Date:  2018-12-13       Impact factor: 3.295

3.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

4.  Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.

Authors:  Didier Mounkoro; Christelle S Nikiema; Issaka Maman; Souleymane Sakandé; Catherine H Bozio; Haoua Tall; Adodo Yao Sadji; Berthe-Marie Njanpop-Lafourcade; Agoro Sibabe; Dadja E Landoh; Essofa O Abodji; Agbenoko Kodjo; Tsidi A Tamekloe; Téné Alima Essoh; Détèma W Maba; Bradford D Gessner; Jennifer C Moïsi
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.